XML 57 R42.htm IDEA: XBRL DOCUMENT
v3.23.1

Business Segment Information (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2023
Notes To Financial Statements [Abstract] |
Schedule of Segment Reporting Information, by Segment |
Years Ended March 31, |  | 2023 |  | 2022 |  | 2021
Revenues: |  |  |  |  |  |
Healthcare |  | $ | 3,085,131 |  |  | $ | 2,845,467 |  |  | $ | 1,954,055 |
Applied Sterilization Technologies |  | 914,431 |  |  | 852,972 |  |  | 685,912 |
Life Sciences |  | 536,704 |  |  | 524,964 |  |  | 467,552 |
Dental |  | 421,573 |  |  | 361,661 |  |  | — |
Total revenues |  | $ | 4,957,839 |  |  | $ | 4,585,064 |  |  | $ | 3,107,519 |
Operating income (loss): |  |  |  |  |  |
Healthcare |  | 706,020 |  |  | 649,704 |  |  | 427,089 |
Applied Sterilization Technologies |  | 429,020 |  |  | 410,101 |  |  | 310,648 |
Life Sciences |  | 210,225 |  |  | 216,188 |  |  | 180,796 |
Dental |  | 89,527 |  |  | 84,441 |  |  | — |
Corporate |  | (264,791) |  |  | (283,665) |  |  | (219,153) |
Total operating income before adjustments |  | $ | 1,170,001 |  |  | $ | 1,076,769 |  |  | $ | 699,380 |
Less: Adjustments |  |  |  |  |  |
Amortization of acquired intangible assets (1) |  | 376,822 |  |  | 366,434 |  |  | 83,892 |
Acquisition and integration related charges (2) |  | 24,196 |  |  | 205,788 |  |  | 35,634 |
Tax restructuring costs (3) |  | 661 |  |  | 301 |  |  | 1,592 |
Gain on fair value adjustment of acquisition related contingent consideration (1) |  | (3,100) |  |  | (2,350) |  |  | (500) |
Net (gain) loss on divestiture of businesses (1) |  | (67) |  |  | (874) |  |  | 2,030 |
Amortization of inventory and property "step up" to fair value (1) |  | 12,254 |  |  | 81,804 |  |  | 5,600 |
COVID-19 incremental costs (4) |  | — |  |  | — |  |  | 25,793 |
Restructuring charges (credit) (5) |  | 485 |  |  | 48 |  |  | (3,029) |
Goodwill impairment loss (6) |  | 490,565 |  |  | — |  |  | — |
Total operating income |  | $ | 268,185 |  |  | $ | 425,618 |  |  | $ | 548,368 |
(1) For more information regarding our recent acquisitions and divestitures, refer to Note 2 titled, "Business Acquisitions and Divestitures." (2) Acquisition and integration related charges include transaction costs and integration expenses associated with acquisitions. (3) Costs incurred in tax restructuring. (4) COVID-19 incremental costs includes the additional costs attributable to COVID-19 such as enhanced cleaning protocols, personal protective equipment for our employees, event cancellation fees, and payroll costs associated with our response to COVID-19, net of any government subsidies available. (5) For more information regarding our restructuring efforts, refer to our Annual Report on Form 10-K for the year ended March 31, 2021, dated May 28, 2021. (6) For more information regarding our goodwill impairment loss, refer to Note 3 titled, "Goodwill and Intangible Assets."
March 31, |  | 2023 |  | 2022
Assets |  |  |  |
Healthcare and Life Sciences |  | $ | 6,538,270 |  |  | $ | 6,604,893 |
Applied Sterilization Technologies |  | 3,124,341 |  |  | 3,053,116 |
Dental |  | 1,159,228 |  |  | 1,765,585 |
Total assets |  | $ | 10,821,839 |  |  | $ | 11,423,594 |
Years Ended March 31, |  | 2023 |  | 2022 |  | 2021
Capital Expenditures |  |  |  |  |  |
Healthcare and Life Sciences |  | $ | 98,585 |  |  | $ | 84,487 |  |  | $ | 74,446 |
Applied Sterilization Technologies |  | 253,914 |  |  | 198,350 |  |  | 164,816 |
Dental |  | 9,470 |  |  | 4,726 |  |  | — |
Total Capital Expenditures |  | $ | 361,969 |  |  | $ | 287,563 |  |  | $ | 239,262 |
Depreciation, Depletion, and Amortization (1) |  |  |  |  |  |
Healthcare and Life Sciences |  | $ | 306,377 |  |  | $ | 316,222 |  |  | $ | 106,266 |
Applied Sterilization Technologies |  | 116,153 |  |  | 115,925 |  |  | 112,971 |
Dental |  | 130,367 |  |  | 120,957 |  |  | — |
Total Depreciation, Depletion, and Amortization |  | $ | 552,897 |  |  | $ | 553,104 |  |  | $ | 219,237 |
(1) Fiscal 2022 totals include approximately $229,052, $35,531 and $113,099 for Healthcare and Life Sciences, Applied Sterilization Technologies, and Dental, respectively, of amortization of acquired intangible assets and amortization of property "step-up" to fair value. For more information regarding our recent acquisitions and divestitures see Note 2 titled, "Business Acquisitions and Divestitures."
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area |
March 31, |  | 2023 |  | 2022
Property, Plant, and Equipment, Net |  |  |  |
Ireland |  | $ | 60,570 |  |  | $ | 60,275 |
United States |  | 946,930 |  |  | 881,057 |
Other locations |  | 698,012 |  |  | 611,244 |
Property, Plant, and Equipment, Net |  | $ | 1,705,512 |  |  | $ | 1,552,576 |
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] |
Years Ended March 31, |  | 2023 |  | 2022 |  | 2021
Revenues: |  |  |  |  |  |
Ireland |  | $ | 74,463 |  |  | $ | 82,011 |  |  | $ | 71,905 |
United States |  | 3,586,486 |  |  | 3,228,864 |  |  | 2,227,038 |
Other locations |  | 1,296,890 |  |  | 1,274,189 |  |  | 808,576 |
Total Revenues |  | $ | 4,957,839 |  |  | $ | 4,585,064 |  |  | $ | 3,107,519 |
Revenue from External Customers by Products and Services [Table Text Block] |
Years Ended March 31, |  | 2023 |  | 2022 |  | 2021
Healthcare: |  |  |  |  |  |
Capital equipment |  | 896,590 |  |  | $ | 782,505 |  |  | $ | 588,864 |
Consumables |  | 1,050,316 |  |  | 1,004,605 |  |  | 510,946 |
Service |  | 1,138,225 |  |  | 1,058,357 |  |  | 854,245 |
Total Healthcare Revenues |  | $ | 3,085,131 |  |  | $ | 2,845,467 |  |  | $ | 1,954,055 |
Applied Sterilization Technologies: |  |  |  |  |  |
Capital equipment |  | $ | 26,460 |  |  | $ | 24,394 |  |  | $ | — |
Service |  | $ | 887,971 |  |  | $ | 828,578 |  |  | $ | 685,912 |
Total Applied Sterilization Technologies Service Revenues |  | $ | 914,431 |  |  | $ | 852,972 |  |  | $ | 685,912 |
Life Sciences: |  |  |  |  |  |
Capital equipment |  | $ | 147,420 |  |  | $ | 142,281 |  |  | $ | 128,356 |
Consumables |  | 241,114 |  |  | 239,365 |  |  | 215,005 |
Service |  | 148,170 |  |  | 143,318 |  |  | 124,191 |
Total Life Sciences Revenues |  | $ | 536,704 |  |  | 524,964 |  |  | 467,552 |
Dental Revenues |  | $ | 421,573 |  |  | $ | 361,661 |  |  | $ | — |
Total Revenues |  | $ | 4,957,839 |  |  | $ | 4,585,064 |  |  | $ | 3,107,519 |

X
- Definition Notes to Financial Statements [Abstract] + References No definition available. + Details
Name: | ste_NotesToFinancialStatementsAbstract
Namespace Prefix: | ste_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph a -SubTopic 10 -Topic 280 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration